Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective study

Individuals with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) have a high risk of developing other malignancies (OMs). The development of OMs may be associated with the advanced age of CLL/SLL patients, presence of a tumor-promoting microenvironment, immune alterations inhe...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical hematology international 2025-01, Vol.7 (1), p.1-9
Hauptverfasser:	Stocker, Nicolas, Alsuliman, Tamim, Corre, Elise, Ricard, Laure, Kaoui, Fazia, Coppo, Paul, Brissot, Eolia, Dulery, Remy, Banet, Anne, Van de Wyngaert, Zoé, Legrand, Ollivier, Bonnin, Agnès, Mohty, Mohamad, Malard, Florent, Marjanovic, Zora
Format:	Artikel
Sprache:	eng
Schlagworte:	Hematology Human health and pathology Life Sciences Systematic Reviews
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!